Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down – What’s Next?

Eurofins Scient (OTCMKTS:ERFSFGet Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $83.51, but opened at $74.79. Eurofins Scient shares last traded at $71.80, with a volume of 151 shares changing hands.

Analyst Ratings Changes

Several research analysts recently commented on ERFSF shares. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. BNP Paribas Exane upgraded Eurofins Scient to an “outperform” rating in a research report on Monday, January 5th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

Read Our Latest Stock Report on ERFSF

Eurofins Scient Price Performance

The business’s fifty day moving average price is $76.44 and its two-hundred day moving average price is $74.94.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Recommended Stories

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.